A new publication by Professor Raoult on Covid deemed “problematic”: why this article is causing a stir

A new publication deemed problematic by Professor Didier Raoult has been reported. EPA – CHRISTOPHE PETIT TESSON

The Assistance publique-Hôpitaux de Marseille and the Fondation Méditerranée Infection have reported to the National Agency for the Safety of Medicines and Health Products (ANSM) a new publication deemed problematic by the controversial Professor Didier Raoult, we learned Thursday from the APHM, confirming information from Point.

This report follows the publication in the August 2024 edition of the journal “Acta Scientific Microbiology” of an article co-signed by Didier Raoult, former head of the IHU Méditerranée Infection in Marseille, and one of his former close collaborators, Philippe Brouqui.

Hydroxychloroquine

This article, based on data from 1,276 patients with Covid treated at the IHU, some of which were treated with hydroxychloroquine, claims to once again demonstrate the effectiveness of this controversial treatment promoted by Professor Raoult.

In their mail, APHM and the Mediterranean Infection Foundation, which oversees the IHU, “report” and are "dissociate" from this article whose methodology is based on "the use of patient data and “unauthorized research”, the APHM said.

Report

According to the institution, this reporting was decided in a "logic of return to normal" at the IHU since the departure of Professor Raoult, today at retirement.

The ANSM had taken legal action in November 2023 after the publication of another study co-signed by Professor Raoult, who had not obtained the mandatory authorizations. The former head of the IHU and his team are suspected of having conducted several “wild” studies at the IHU during the Covid epidemic.